Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis

Spontaneous tumour lysis syndrome

(2012) N. Kekre et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

(2011) S. Vadhan-Raj et al.   ANNALS OF ONCOLOGY

Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: A case series and literature review

(2011) Joen CHIANG et al.   Asia-Pacific Journal of Clinical Oncology

Oncology: Fixed-Dose Rasburicase 6 mg for Hyperuricemia and Tumor Lysis Syndrome in High-Risk Cancer Patients

(2010) Ashleigh N Vines et al.   ANNALS OF PHARMACOTHERAPY

Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies

(2010) S M Trifilio et al.   BONE MARROW TRANSPLANTATION

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

(2010) Jorge Cortes et al.   JOURNAL OF CLINICAL ONCOLOGY

Reply to M. Darmon et al

(2010) Jorge E. Cortes   JOURNAL OF CLINICAL ONCOLOGY

Rasburicase and Tumor Lysis Syndrome: Lower Dosage, Consideration of Indications, and Hyperhydration

(2010) Michaël Darmon et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome

(2010) Randall W Knoebel et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome

(2009) Tariq I. Mughal et al.   CANCER TREATMENT REVIEWS

A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function

(2009) Mariano Malaguarnera et al.   EXPERT OPINION ON PHARMACOTHERAPY

Single dose rasburicase in tumor lysis: One hospital's experience

(2008) Simone STEEL et al.   Asia-Pacific Journal of Clinical Oncology

Tumor lysis syndrome: current perspective

(2008) J. Hochberg et al.   HAEMATOLOGICA

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

(2008) P. Montesinos et al.   HAEMATOLOGICA

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

(2008) Bertrand Coiffier et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach

(2008) M. Campara et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Evaluation of a Single Fixed Dose of Rasburicase 7.5 mg for the Treatment of Hyperuricemia in Adults with Cancer

(2008) David J Reeves et al.   PHARMACOTHERAPY